Hematopoietic growth factors: ESMO recommendations for the application.

Richard Greil* (First author), Oskar Psenak (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

8 Citations (Web of Science)
Original languageEnglish
Pages (from-to)ii89-ii91
JournalANNALS OF ONCOLOGY
Volume18 Suppl 2
DOIs
Publication statusPublished - 2007

Keywords

  • SINGLE-ADMINISTRATION PEGFILGRASTIM
  • DOUBLE-BLIND
  • DAILY FILGRASTIM
  • BREAST-CANCER
  • PHASE-III
  • CHEMOTHERAPY
  • MULTICENTER
  • CYCLE
  • RISK

Cite this